Novocure Ltd stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Novocure Ltd stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Novocure Ltd do? Business model and key facts
Get the full picture of Novocure Ltd: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Devices
Employees (FY): 1605
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Stocks related to Novocure Ltd
Selected based on industry alignment and relative market positioning.
Events and news impacting Novocure Ltd stock
Earnings, coporate decisions and industry developments that can affect the share price.
Novocure Ltd fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
